A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

Circular RNA ZBTB46 Attenuates Apoptosis and Oxidative Stress in Lipopolysaccharide-Injured Human Endothelial Cells by Modulating ERBB2-AKT Signaling

222 views

DOI:

10.3791/69765

February 13th, 2026

In This Article

Summary

Sepsis-associated acute kidney injury (SA-AKI) is associated with considerable mortality rates. This study finds circZBTB46 downregulated in LPS-induced HUVECs (SA-AKI in vitro). Its overexpression boosts HUVEC viability, reduces apoptosis, inflammation, and oxidative stress in association with ERBB2/AKT signaling, suggesting a potential therapeutic target relevant to SA-AKI.

Abstract

Circular RNAs are emerging regulators of stress responses, yet their roles in endothelial injury that leads to sepsis-related acute kidney injury remain incompletely defined. We hypothesized that the circular RNA ZBTB46 (circZBTB46) confers endothelial protection by engaging ERBB2-AKT signaling. Using a cell-based model in which human umbilical vein endothelial cells were challenged with lipopolysaccharide, we quantified circZBTB46 expression and tested the effects of its forced expression on survival, apoptosis, inflammatory mediators, and redox homeostasis. Cell viability assays and flow cytometry assessed survival and apoptosis. Enzyme-linked immunosorbent assays measured interleukin-6, tumor necrosis factor-α, and interleukin-1β, while reactive oxygen species, malondialdehyde, superoxide dismutase, and catalase were evaluated as indices of oxidative injury and antioxidant capacity. To define the mechanism, we performed transcriptome profiling with gene set enrichment analysis, confirmed pathway proteins by Western blotting, and assessed the necessity using the ERBB2 inhibitor AG-825. Lipopolysaccharide suppressed circZBTB46. CircZBTB46 overexpression increased viability, lowered apoptosis, reduced pro-inflammatory cytokines and reactive oxygen species, decreased malondialdehyde, and raised superoxide dismutase and catalase activities. Transcriptomic and protein analyses supported activation of the ERBB2-AKT axis, and pharmacologic ERBB2 blockade blunted cytoprotection and reversed gains in redox balance. These findings identify circZBTB46 as an endogenous brake on lipopolysaccharide-induced endothelial damage through ERBB2-AKT signaling and nominate circZBTB46 as a mechanistic node and potential therapeutic target for sepsis-related acute kidney injury.

Introduction

Sepsis, a life-threatening systemic inflammatory cascade initiated by pathogenic invasion, frequently culminates in multi-organ failure1. Within this critical context, SA-AKI emerges as a predominant and clinically significant complication in intensive care units2. Characterized by abrupt deterioration of renal filtration capacity concurrent with systemic infection, this condition demonstrates mortality rates exceeding those of non-septic AKI by 38%-42% in clinical cohorts2. Approximately 60% of individuals diagnosed with sepsis or septic shock are anticipated to develop SA-AKI3<....

Access restricted. Please log in or start a trial to view this content.

Protocol

This protocol describes the experimental procedures used to investigate the effects of circZBTB46 modulation on inflammatory signaling, oxidative stress, and ERBB2-AKT pathway activation in HUVECs.

Cell culture
The HUVECs cells used in this study were obtained from a commercial source. HUVECs were used as a representative endothelial cell model because of their wide availability, reproducible culture conditions, and high transfection efficiency, which facilitate genetic manipulation and mechanistic investigation of endothelial signaling pathways under inflammatory stress15,<....

Access restricted. Please log in or start a trial to view this content.

Results

qRT-PCR analysis of circZBTB46 expression in an in vitro SA-AKI model
This set of experiments was conducted to test the hypothesis that circZBTB46 expression is altered under LPS stimulation and that modulation of circZBTB46 affects endothelial cell viability and apoptosis in an in vitro SA-AKI model. Initially, circZBTB46 expression was examined under control conditions and in an.......

Access restricted. Please log in or start a trial to view this content.

Discussion

During sepsis, pathogen-associated molecular patterns (PAMPs), such as LPS released by pathogens, activate Toll-like receptors (e.g., TLR4), initiating a systemic inflammatory response26. This process triggers the secretion of multiple pro-inflammatory mediators, such as TNF-α, IL-6, and IL-1β, resulting in a cytokine storm27. Simultaneously, LPS directly damages vascular endothelial cells, resulting in microcirculatory disturbances, increased vascular permeabilit.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no competing interests. The authors declare that the main results presented in this manuscript have not been published previously and are not under consideration for publication elsewhere.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
AG-825 (ErbB2 Inhibitor)MedChemExpressHY-1019710 μM for pathway blockade
Agilent 2100 BioanalyzerAgilentG2939BARNA integrity (RIN≥7)
AKT AntibodyProteintech60203-2-IgWB (1:15000)
Annexin V-APC/PI Apoptosis KitElabscienceE-CK-A327Apoptosis detection
Antibiotic-AntimycoticGibco152400621% concentration
BCA Protein Quantification KitBeyotimeP0012Protein concentration
CAT ELISA KitMEIMIANMM-0897H2Antioxidant enzyme
CCK-8 KitDojindoCK04Cell viability assay
CircRNA seqFuzhou Huarong Kehui Biotechnology Co., Ltd.PE150CircRNA sequencing and all associated bioinformatic analyses
CytoFLEX Flow CytometerBeckman CoulterB53000Apoptosis analysis
DMEMGibco (Invitrogen)11965092Cell culture medium
ECL Substrate KitMilliporeWBKLS0100Protein detection
ERBB2 AntibodySino Biological100271-T32WB (1:10000)
Fetal Bovine Serum (FBS)Biological Industries04-001-1ACS10% (v/v) supplement
GAPDH AntibodyProteintech60004-1-IgWB (1:50000)
HUVECsProcell systemCP-H082Source of cell line
IL-1β ELISA KitMEIMIANMM-0181H2Inflammatory factor
IL-6 ELISA KitMEIMIANMM-0049H2Inflammatory factor
Illumina NovaSeq 6000Illumina20012850RNA sequencing
Lipofectamine 3000InvitrogenL3000008Transfection reagent
LPS (E. coli O111:B4)Sigma-AldrichL263010 μg/mL for SA-AKI model
MDA ELISA KitMEIMIANMM-2037H2Oxidative stress marker
NanoDrop 2000Thermo FisherND-2000RNA quantification
NEBNext Ultra II RNA Library KitNEBE7770SRNA-seq library prep
oe-circZBTB46 plasmidGenScriptCustom synthesiscircZBTB46 overexpression vector
oe-NC plasmidGenScriptCustom synthesisNegative control vector
p-AKT (Ser473) AntibodyProteintech66444-1-IgWB (1:1200)
PrimeScript RT Reagent KitTakaraRR047AcDNA synthesis
PVDF MembranesMilliporeIPVH00010Western blot transfer
QuantStudio 5 SystemThermo FisherA28137Real-time PCR
Ribonuclease RLucigenRNR07250rRNA removal
RIPA Lysis BufferBeyotimeP0013BProtein extraction
RNAiso PlusTakara9109Total RNA extraction
SOD ELISA KitMEIMIANMM-25469H2Antioxidant enzyme
TB Green Premix Ex TaqTakaraRR420AqPCR reagent
TNF-α ELISA KitMEIMIANMM-0122H2Inflammatory factor

References

  1. Vincent, J. L. Current sepsis therapeutics. EBioMedicine. 86, 104318(2022).
  2. White, K. C., et al. Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

CircZBTB46Lipopolysaccharide InjuryApoptosis RegulationCell Viability AssayFlow CytometryAcute Kidney Injury